Palestinian Breast Cancer Patient Data with Hormone Receptor and IGF Biomarkers

112 newly diagnosed breast cancer patients from a cross-sectional study in the Gaza Strip. The dataset includes structured interview data, laboratory analyses for IGF-1 and IGFBP-3 levels, genetic data for the IGFBP-3 A-202C polymorphism, and immunohistochemical assessments for ER, PR, and HER-2 status. Heba Mohammed Arafat published the dataset on figshare in 2026.

Use Cases

• Investigate associations between serum IGF-1 levels and hormone receptor status (ER/PR) based on the described positive correlation.
• Analyze the relationship between the IGFBP-3 A-202C genotype and progesterone receptor (PR) positivity based on the significant association reported.
• Model breast cancer risk or progression based on combined genetic, biochemical, and hormone receptor status features mentioned in the description.
• Study the prevalence of hormone receptor positivity (ER+, PR+, HER-2-) in a specific patient cohort based on the reported percentages.

Strengths

• Includes data from 112 newly diagnosed, histopathologically confirmed breast cancer patients.
• Integrates multiple data types: structured interviews, biochemical assays, genetic polymorphism data, and immunohistochemical assessments.
• Reports specific prevalence statistics: 87.5% ER positive, 84.8% PR positive, and 75.9% HER-2 negative among patients.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is very small at 74.5 KB, indicating limited scope.

Provenance

Source

Heba Mohammed Arafat via figshare.

Collection Method

Cross-sectional study involving structured interviews and laboratory analyses (biochemical, genetic, immunohistochemical).

Freshness

Last updated 2026-06-01 17:31:20; freshness should be verified.

Geography

Likely focuses on Palestinian women, specifically mentioned in the context of the Gaza Strip.